Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
McPherson M, Economidou S, Liampas A, Zis P, Parperis K.
Semin Arthritis Rheum. 2022 Apr;53:151959. doi: 10.1016/j.semarthrit.2022.151959. Epub 2022 Jan 31.
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.
Chen Z, Wang X, Ye S.
N Engl J Med. 2019 Jul 18;381(3):291-293. doi: 10.1056/NEJMc1900045.
Amyopathic dermatomyositis combined with peripheral neuropathy.
Miyake Z, Ishii A, Okiyama N, Tamaoka A.
BMJ Case Rep. 2020 Nov 30;13(11):e237250. doi: 10.1136/bcr-2020-237250.
Amyopathic dermatomyositis may be on the spectrum of autoinflammatory disease: A clinical review.
Sharmeen S, Christopher-Stine L, Salvemini JN, Gorevic P, Clark R, Yao Q.
Rheumatol Immunol Res. 2024 Mar 31;5(1):42-48. doi: 10.1515/rir-2024-0005. eCollection 2024 Mar.
Clinically amyopathic dermatomyositis.
Sato S, Kuwana M.
Curr Opin Rheumatol. 2010 Nov;22(6):639-43. doi: 10.1097/BOR.0b013e32833f1987.
Dermatomyositis.
Qudsiya Z, Waseem M.
2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Amyopathic dermatomyositis: definitions, diagnosis, and management.
Bailey EE, Fiorentino DF.
Curr Rheumatol Rep. 2014 Dec;16(12):465. doi: 10.1007/s11926-014-0465-0.
Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies.
Udkoff J, Cohen PR.
Am J Clin Dermatol. 2016 Oct;17(5):509-518. doi: 10.1007/s40257-016-0199-z.
Juvenile amyopathic dermatomyositis.
Napolitano M, Megna M, Squillace L, Costa C, Scalvenzi M.
G Ital Dermatol Venereol. 2019 Apr;154(2):215-216. doi: 10.23736/S0392-0488.17.05696-6. Epub 2017 Jul 11.
Research progress on amyopathic dermatomyositis associated with interstitial lung disease.
Bai Y, Tao XN.
Chin Med J (Engl). 2020 Jan 5;133(1):111-113. doi: 10.1097/CM9.0000000000000574.
